{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:57:06Z","timestamp":1776293826237,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000262","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["PPA-0517-0717-RAD"],"award-info":[{"award-number":["PPA-0517-0717-RAD"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["TA-GT-0521-0799-RAD-TRAP"],"award-info":[{"award-number":["TA-GT-0521-0799-RAD-TRAP"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xops.2025.101021","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:13:37Z","timestamp":1764173617000},"page":"101021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Comparison of Randomizing Either One Eye or Both Eyes in Clinical Trials for Stargardt Disease Type 1"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-6690","authenticated-orcid":false,"given":"Jeroen A.A.H.","family":"Pas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-1668","authenticated-orcid":false,"given":"Patty P.A.","family":"Dhooge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherina H.Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob W.J.","family":"Collin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carel B.","family":"Hoyng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6127-0747","authenticated-orcid":false,"given":"Joanna","family":"IntHout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.101021_bib1","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.3390\/jcm13185512","article-title":"Update on clinical trial endpoints in gene therapy trials for inherited retinal diseases","volume":"13","author":"Igoe","year":"2024","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.xops.2025.101021_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.7.2","article-title":"Advancing clinical trials for inherited retinal diseases: recommendations from the Second Monaciano Symposium","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2025.101021_bib3","series-title":"Retinal Dystrophies and Degenerations","first-page":"135","article-title":"Fundus flavimaculatus","author":"Blacharski","year":"1988"},{"key":"10.1016\/j.xops.2025.101021_bib4","article-title":"Characteristics of design and analysis of ophthalmic randomized controlled trials: a review of papers in four ophthalmology journals in 2020-2021","volume":"3","author":"Dong","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.101021_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ophtha.2011.09.025","article-title":"Eyes or subjects: are ophthalmic randomized controlled trials properly designed and analyzed?","volume":"119","author":"Lee","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.101021_bib6","first-page":"495","article-title":"Stargardt macular dystrophy and therapeutic approaches","volume":"108","author":"Fujinami","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.101021_bib7","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.3390\/ijms25168859","article-title":"Emerging therapeutic approaches and genetic insights in Stargardt disease: a comprehensive review","volume":"25","author":"Ghenciu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2025.101021_bib8","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.3390\/jcm12196229","article-title":"Updates on emerging interventions for autosomal recessive ABCA4-associated Stargardt disease","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2025.101021_bib9","series-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"10.1016\/j.xops.2025.101021_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1167\/iovs.66.4.76","article-title":"Progression of atrophy as a function of ABCA4 variants and age of onset in Stargardt disease","volume":"66","author":"Pas","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.101021_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archopht.1992.01080170112036","article-title":"Sample size calculation for ophthalmic studies","volume":"110","author":"Gauderman","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.101021_bib12","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ophtha.2019.05.015","article-title":"Natural history of autosomal recessive Stargardt disease in untreated eyes: a systematic review and meta-analysis of study- and individual-level data","volume":"126","author":"Shen","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.101021_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2024.07.035","article-title":"Progression rate of macular retinal pigment epithelium atrophy in geographic atrophy and selected inherited retinal dystrophies. A systematic review and meta-analysis","volume":"269","author":"Bassil","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.101021_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/genes10060452","article-title":"Antisense oligonucleotide screening to optimize the rescue of the splicing defect caused by the recurrent deep-intronic ABCA4 variant c.4539+2001G>A in Stargardt disease","volume":"10","author":"Garanto","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.xops.2025.101021_bib15","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1038\/mtna.2012.3","article-title":"Antisense oligonucleotide (AON)-based therapy for Leber congenital amaurosis caused by a frequent mutation in CEP290","volume":"1","author":"Collin","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.xops.2025.101021_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","article-title":"Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect","volume":"25","author":"Cideciyan","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.xops.2025.101021_bib17","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.3390\/cells11243947","article-title":"Correction of the splicing defect caused by a recurrent variant in ABCA4 (c.769-784C>T) that underlies Stargardt disease","volume":"11","author":"Tomkiewicz","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.xops.2025.101021_bib18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41591-022-01755-w","article-title":"Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b\/2 trial","volume":"28","author":"Russell","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.xops.2025.101021_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00417-023-06292-x","article-title":"Clinical classification of Stargardt disease","volume":"262","author":"Pas","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2025.101021_bib21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaophthalmol.2015.2757","article-title":"Considerations for randomizing 1 eye or 2 eyes","volume":"133","author":"Bunce","year":"2015","journal-title":"JAMA Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525003197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525003197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:59:35Z","timestamp":1773964775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525003197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666914525003197"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.101021","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Randomizing Either One Eye or Both Eyes in Clinical Trials for Stargardt Disease Type 1","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.101021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"101021"}}